VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q89741721 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010857.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q89741721‏
024 ‎‡a 0000-0002-9969-3681‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q89741721‏
100 0 ‎‡a Ke Xu‏ ‎‡c researcher (ORCID 0000-0002-9969-3681)‏ ‎‡9 en‏
670 ‎‡a Author's A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism‏
670 ‎‡a Author's A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial‏
670 ‎‡a Author's B-Cell-Epitope-Based Fluorescent Quantum Dot Biosensors for SARS-CoV-2 Enable Highly Sensitive COVID-19 Antibody Detection‏
670 ‎‡a Author's Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2‏
670 ‎‡a Author's Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation.‏
670 ‎‡a Author's Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2‏
909 ‎‡a (orcid) 0000000299693681‏ ‎‡9 1‏
919 ‎‡a proteincoevolutionmethoduncoverscriticalfeaturesofthehepatitis100virusfusionmechanism‏ ‎‡A A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism‏ ‎‡9 1‏
919 ‎‡a smallscalemedicationofleflunomideasatreatmentofcovid19inanopenlabelblankcontrolledclinicaltrial‏ ‎‡A A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial‏ ‎‡9 1‏
919 ‎‡a bcellepitopebasedfluorescentquantumdotbiosensorsforsarscov2enablehighlysensitivecovid19antibodydetection‏ ‎‡A B-Cell-Epitope-Based Fluorescent Quantum Dot Biosensors for SARS-CoV-2 Enable Highly Sensitive COVID-19 Antibody Detection‏ ‎‡9 1‏
919 ‎‡a correctiontonovelandpotentinhibitorstargetingdhodharebroadspectrumantiviralsagainstrnavirusesincludingnewlyemergedcoronavirussarscov2‏ ‎‡A Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2‏ ‎‡9 1‏
919 ‎‡a histonedemethylaselsd1restrictsinfluenzaavirusinfectionbyerasingifitm3k88monomethylation‏ ‎‡A Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation.‏ ‎‡9 1‏
919 ‎‡a novelandpotentinhibitorstargetingdhodharebroadspectrumantiviralsagainstrnavirusesincludingnewlyemergedcoronavirussarscov2‏ ‎‡A Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2‏ ‎‡9 1‏
996 ‎‡2 LC|no 99010566
996 ‎‡2 LC|n 81084589
996 ‎‡2 LC|no2021009952
996 ‎‡2 ISNI|0000000431464852
996 ‎‡2 SUDOC|255103905
996 ‎‡2 CYT|AC000632389
996 ‎‡2 SUDOC|171568583
996 ‎‡2 DNB|1216206171
996 ‎‡2 NKC|pna2007384023
996 ‎‡2 LC|no2017105209
996 ‎‡2 RERO|A019062869
996 ‎‡2 PLWABN|9812620065305606
996 ‎‡2 J9U|987007316929205171
996 ‎‡2 CYT|AC000207498
996 ‎‡2 DNB|1203318251
996 ‎‡2 DNB|1325231649
996 ‎‡2 CAOONL|ncf11870259
996 ‎‡2 DNB|1171172435
996 ‎‡2 LC|n 2009041685
996 ‎‡2 NLA|000036730815
996 ‎‡2 ISNI|0000000430745986
996 ‎‡2 RERO|A024001858
996 ‎‡2 DNB|1217436588
996 ‎‡2 LC|no2021040126
996 ‎‡2 CYT|AC000008445
996 ‎‡2 NDL|001155350
996 ‎‡2 LC|n 2014182949
996 ‎‡2 ISNI|0000000496624546
996 ‎‡2 LC|n 2021182681
996 ‎‡2 CYT|AC000006331
996 ‎‡2 SUDOC|077446542
996 ‎‡2 SUDOC|262492237
996 ‎‡2 LC|n 2016041159
996 ‎‡2 DNB|1012430537
996 ‎‡2 LC|n 85370139
996 ‎‡2 DNB|1056993243
996 ‎‡2 ISNI|0000000082854480
996 ‎‡2 NSK|000606243
996 ‎‡2 SUDOC|264198050
996 ‎‡2 DNB|113272743X
996 ‎‡2 NTA|322055326
996 ‎‡2 NLA|000036730776
996 ‎‡2 NII|DA13429885
996 ‎‡2 NUKAT|n 2009097276
996 ‎‡2 DNB|133315819
996 ‎‡2 BNE|XX1287862
996 ‎‡2 NYNYRILM|91388
996 ‎‡2 CYT|AC000581700
996 ‎‡2 CAOONL|ncf11892979
996 ‎‡2 DNB|1132073243
996 ‎‡2 SUDOC|184748348
996 ‎‡2 DNB|1140028286
996 ‎‡2 DNB|1325265896
996 ‎‡2 CYT|AC000631336
996 ‎‡2 J9U|987007349772605171
996 ‎‡2 DNB|13627773X
996 ‎‡2 DNB|1137016582
996 ‎‡2 NTA|169320944
996 ‎‡2 BNF|14022926
996 ‎‡2 CYT|AC000224849
996 ‎‡2 NTA|317862677
996 ‎‡2 CYT|AC000638917
996 ‎‡2 ISNI|0000000500667793
996 ‎‡2 BIBSYS|11011746
996 ‎‡2 NKC|xx0281905
996 ‎‡2 CYT|AC000653313
996 ‎‡2 SUDOC|123914051
996 ‎‡2 SUDOC|203897862
996 ‎‡2 ISNI|0000000064164427
996 ‎‡2 DNB|1021990353
996 ‎‡2 CYT|AC000647366
996 ‎‡2 SUDOC|200386174
996 ‎‡2 DNB|1350348902
996 ‎‡2 CYT|AC000639528
996 ‎‡2 KRNLK|KAC200700483
996 ‎‡2 DNB|1211962172
996 ‎‡2 CAOONL|ncf11572463
996 ‎‡2 LC|n 2020015409
996 ‎‡2 CYT|AC000648443
996 ‎‡2 RERO|A003348241
996 ‎‡2 NYNYRILM|284223
996 ‎‡2 SUDOC|070698023
996 ‎‡2 ISNI|0000000064878139
996 ‎‡2 NTA|140852891
996 ‎‡2 CYT|AC000639530
996 ‎‡2 LC|nb2021005975
996 ‎‡2 LC|no2019132051
996 ‎‡2 NTA|327851562
996 ‎‡2 NSK|000526951
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏